Published August 5, 2026
A federal jury in Boston returned an $88 million verdict on August 4, 2026, finding that Medtronic's Covidien unit failed to adequately warn about the risks of its Symbotex hernia mesh. The award, split between compensatory and additional damages, went to Larry Patterson and his wife, Tammy, after a three-week trial — the first bellwether case to reach a verdict out of more than 2,200 Covidien hernia mesh lawsuits consolidated in the federal MDL.
This is the outcome of the trial Atumio reported on when it began in July 2026, after a judge rejected Medtronic's request to have the case thrown out before trial. It's now the largest verdict recorded in the broader hernia and transvaginal mesh litigation to date.
Patterson had a Symbotex mesh implanted during hernia repair surgery in 2017. According to the lawsuit, the mesh caused a bowel obstruction in 2020 that required significant reconstructive surgery. A central issue at trial was a change Covidien made to the mesh's coating material, switching from bovine (cow-derived) collagen to a porcine (pig-derived) collagen. Patterson's attorneys argued Covidien knew the pig-based coating wouldn't hold up as long in the body but didn't warn physicians about the difference. The jury agreed the warning was inadequate.
Bellwether trials are used specifically to test how juries respond to the evidence and arguments common across a large group of consolidated cases — the outcome doesn't decide any other person's case directly, but it often shapes settlement negotiations for the thousands of similar claims still pending against the same manufacturer. Medtronic has not indicated whether it will appeal.
If you had hernia repair surgery involving a mesh implant and later experienced complications such as chronic pain, infection, mesh migration, or a follow-up surgery, see Atumio's hernia mesh case page for a free eligibility review, or start your case review directly.